Affiliate Disclosure
Affiliate Disclosure DailyForex.com adheres to strict guidelines to preserve editorial integrity to help you make decisions with confidence. Some of the reviews and content we feature on this site are supported by affiliate partnerships from which this website may receive money. This may impact how, where and which companies / services we review and write about. Our team of experts work to continually re-evaluate the reviews and information we provide on all the top Forex / CFD brokerages featured here. Our research focuses heavily on the broker’s custody of client deposits and the breadth of its client offering. Safety is evaluated by quality and length of the broker's track record, plus the scope of regulatory standing. Major factors in determining the quality of a broker’s offer include the cost of trading, the range of instruments available to trade, and general ease of use regarding execution and market information.

Forex Today: U.S. Dollar Declines into Year-End

The year-end risk-on rally continues.

  • Stock markets have been mostly continuing to rise. The risk-on year-end rally has been boosted by the passage of a new economic stimulus bill in the U.S., although the U.S. Senate seems certain to keep individual payouts capped at $600 instead of the $2K that the President and House want which has slightly dampened the bullishness.
  • Most major currencies are in strong, long-term bullish trends against the U.S. dollar, with the euro, the British pound, and the Australian dollar hitting multi-year high prices. These trends are now reasserting themselves, with the dollar clearly the weakest major currency while the Australian dollar looks particularly strong.

  • Bitcoin rose firmly yesterday to hit another new all-time record high against the U.S. dollar, trading above $29,000 per coin.
  • The British Parliament approved the Brexit trade deal agreed last week with the E.U. yesterday. The pound rose firmly with the GBP/USD currency pair hitting new long-term highs above 1.3600.
  • The U.K. has become the first country to approve the use of its new Oxford/Astra-Zeneca vaccine, which will be rolled out on 4th January 2021.
  • Yesterday saw a record high number of confirmed coronavirus deaths globally at 14,748, boosted by a similar record number in the U.S.A. of over 3,900. The U.K. saw almost 1,000 deaths and over 50,000 while South Africa reported a record high daily number of new cases. The U.K. has imposed new restrictions on a majority of its population to try to curb the spread, as many analysts are estimating more than 2% of its entire population is currently infected.
  • Global coronavirus deaths have increased dramatically since early October to reach a level approximately 70% higher than the peak last April.
  • Total confirmed new coronavirus cases worldwide stand at over 82.7 million with an average case fatality rate of 2.18%.
  • The coronavirus vaccine drive has been criticized in the U.S. and E.U. for its relatively slow pace so far. It has been progressing fastest in Israel, which has already administered a first shot to 30% of its population over the age of 60.
  • The rate of new coronavirus infections appears to now be increasing most quickly in Andorra, Argentina, Bahrain, Bolivia, Canada, Cuba, Cyprus, Egypt, El Salvador, Honduras, Indonesia, Ireland, Israel, Japan, South Korea, Malaysia, Mali, Malta, Norway, Panama, Russia, San Marino, Sri Lanka, Sweden, Thailand, Tunisia, the U.S.A., and the U.K.
Adam Lemon
About Adam Lemon

Adam Lemon began his role at DailyForex in 2013 when he was brought in as an in-house Chief Analyst. Adam trades Forex, stocks and other instruments in his own account. Adam believes that it is very possible for retail traders/investors to secure a positive return over time provided they limit their risks, follow trends, and persevere through short-term losing streaks – provided only reputable brokerages are used. He has previously worked within financial markets over a 12-year period, including 6 years with Merrill Lynch.

 

Most Visited Forex Broker Reviews